Glucagon ball and stick model
Find information on thousands of medical conditions and prescription drugs.

Glucagon

Glucagon is a 29-amino acid polypeptide acting as an important hormone in carbohydrate metabolism. The polypeptide has a molecular weight of 3485 daltons and was discovered in 1923 by Kimball and Murlin. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
Gabapentin
Gabitril
Galantamine
Gamma-hydroxybutyrate
Ganciclovir
Garamycin
Gaviscon
Gemcitabine
Gemfibrozil
Gemhexal
Gemzar
Generlac
Gentamicin
Geodon
Gleevec
Gliadel
Gliadel Wafer
Glibenclamide
Glimepiride
Glipizide
Glucagon
Glucobay
Glucohexal
Glucophage
Glucosamine
Glucotrol
Glutethimide
Golytely
Gonadorelin
Goserelin
Gramicidin
Gramicidin S
Granisetron
Grifulvin V
Griseofulvin
Guaifenesin
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Its primary structure is: NH2-His-Ser-Gln-Gly-Thr-Phe- Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser- Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu- Met-Asn-Thr-COOH

History

In the 1920s, Kimball and Murlin studied pancreatic extracts and found an additional substance with hyperglycemic properties. Glucagon was sequenced in the late-1950s, but a more complete understanding of its role in physiology and disease was not established until the 1970s, when a specific radioimmunoassay was developed.

Physiology

The hormone is synthesized and secreted from alpha cells of the Islets of Langerhans, which are located in the pancreas. The alpha cells are located in the outer rim of the islet.

Regulation

Stimulus for increased secretion of glucagon

  • Decreased plasma glucose
  • Increased catecholamines
  • Increased plasma amino acids (to protect from hypoglycemia if an all protein meal consumed)
  • Sympathetic nervous system

Stimulus for decreased secretion of glucagon

  • Somatostatin
  • Insulin

Function

  • Glucagon helps maintain the level of glucose in the blood by binding to specific receptors on hepatocytes, causing the liver to release glucose - stored in the form of glycogen - through a process known as glycogenolysis. As these stores become depleted, glucagon then encourages the liver to synthesize additional glucose by gluconeogenesis. This glucose is released into the bloodstream. Both of these mechanisms lead to glucose release by the liver, preventing the development of hypoglycemia.
  • Increased free fatty acids and ketoacids into the blood
  • Increased urea production

Mechanism of action

  • Acts via cAMP generation

Pathology

Abnormally-elevated levels of glucagon may be caused by pancreatic cancers such as glucagonoma, symptoms of which include necrolytic migratory erythema (NME).

Pharmacological application of glucagon

An injectable form of glucagon is essential first aid in cases of severe hypoglycemia. The glucagon is given by intramuscular injection, and quickly raises blood glucose levels. It works only if there is glycogen stored in liver cells, and it won't work again until those stores are replenished.

Glucagon has also inotropic properties. Although its use is impracticable in heart failure, it has some value in treatment of myocardial depression secondary to betablocker overdose. However there have been no clinical controlled trial on the use of glucagon.

Media


Read more at Wikipedia.org


[List your site here Free!]


Current Views on Hypoglycemia and Glucagon: Proceedings (Serono Symposia : No 30) $134.99 Vip, Pacap, Glucagon, and Related Peptides: Fourth International Symposium (Annals of the New York Academy of Sciences) $37.77
Glucagon in Gastroenterology and Hepatology : Pharmacological, Clinical and Therapeutic Implications $94.99

Pancreatic effects of EDCs: low doses can impair glucagon secretion
Endocrine-disrupting chemicals (EDCs) mimic naturally occurring hormones such as estrogen by occupying hormone receptors and triggering a reaction in ...
Intestinal Growth in Parenterally-Fed Rats Induced by the Combined Effects of Glucagon-like Peptide 2 and Epidermal Growth Factor
ABSTRACT. Background: Parenteral nutrition and the absence of luminal feeding result in impaired intestinal growth and differentiation of enterocytes.
Dexamethasone Plus Glucagon-like Peptide 2 Given to Lactating Rat Dams Has a Late Effect on Intestinal Lipid Uptake in the Weanling Offspring
ABSTRACT. Background: Glucagon-like peptide 2 (GLP-2) has a trophic effect on the intestine and enhances intestinal absorption in adult animals, but its ...
Comparative effects of glucagon-like peptide-2, growth hormone, keratinocyte growth factor in rats after massive small bowel resection
Background: Exogenous administration of selected growth factors exert gut-trophic effects and may improve mucosal redox status. However, little comparative ...
GlucaGen® HypoKit : an important consideration for all patients treated with insulin - glucagon rys
Many patients treated with insulin will experience severe hypoglycaemia at some time; yet relatively few have glucagon on hand. This is despite the fact that severe hypoglycaemia is considered to b
A potential role for glucagon in the treatment of drug-induced symptomatic bradycardia
Nine cases of symptomatic bradycardia are presented in which treatment with intravenous glucagon was administered when atropine failed to improve the patient's condition significantly. Although the c
Letters - Evidence does not rule out use of glucagon by people with type 2 diabetes - Clarification needed on issues concerning Muslim patients - Letter
Evidence does not rule out use of glucagon by people with type 2 diabetes We read with great interest the learning module on hypoglycaemia in the Spring 2001 issue. However, we were concerned abo
The Effects Of Microgravity On Insulin And Glucagon Secretions
THE EFFECTS OF MICROGRAVITY ON INSULIN AND GLUCAGON SECRETIONS.

Home Contact Resources Exchange Links ebay